心律不整的自主神经元调节:当前的概念和新兴的疗法
Ravina Rai1, Virendra Singh2, Zaved Ahmad1
1Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar 470003 MP, India.
Physiology & behavior
|March 25, 2024
概括
自主调制通过向神经系统,为心律失常,如心房动和心室性心跳动提供了有前途的新疗法. 这些技术利用神经可塑性产生治疗效果,在早期研究中显示出潜力.
科学领域:
- 心脏病学 心脏病学
- 神经科学是一个神经科学.
- 自主神经系统研究 自主神经系统研究
背景情况:
- 心律不整,包括心房动和心室低心率,涉及复杂的自主神经系统机制.
- 目前对这些心律失常的理解需要探索超越传统方法的新疗法.
研究的目的:
- 突出使用自主调制治疗心律失常的有希望的临床前和临床治疗方法.
- 为了引起人们对调节自主神经系统对心律不规则的治疗潜力的注意.
主要方法:
- 审查自主调节技术:迷走神经刺激,轨道神经刺激,脏缩,心脏交感性缩和巴罗受体激活.
- 检查临床前和早期临床证据,支持自主系统在心律失常控制中的作用.
- 测量自主音调的方法概述,包括心率振荡和交感神经活动.
主要成果:
- 自主调制显示了重塑神经组织的潜力,并在心律失常时提供治疗效果.
- 临床前和早期人类研究表明,交感和副交感系统可以影响心脏肌细胞和心肌.
- 心率振荡和交感神经活动显示出作为自主调制疗法的结果预测指标的希望.
结论:
- 自主调制代表了一种正在发展的治疗策略,用于治疗心律失常.
- 对这些技术的进一步研究是有必要的,以充分了解它们的临床疗效.
- 测量自主声调可能为心律失常管理的治疗结果提供有价值的见解.
相关概念视频
Mechanism of Cardiac Arrhythmias
918
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
918
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Regulation of Heart Rates
1.8K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.8K
Disturbances in Heart Rhythm
950
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
950
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


